Hans-Joachim Anders
Professor, University of Munich and Editor-in-Chief at Nephrology Dialysis Transplantation
Physician scientist at LMU Munich searching ways to maximize kidneys` lifespan, EiC of NDT
Articles
-
Dec 8, 2024 |
nature.com | Hans-Joachim Anders
Correction to: Nature Reviews Rheumatology https://doi.org/10.1038/s41584-024-01158-w, published online 24 September 2024. In the version of the article initially published, in Fig. 2b, the label “IIanalumab” was incorrect and has now been amended to “Ianalumab”. Additionally, the target of Ianalumab was incorrectly shown to be BAFF-R/BCMA/TACI, and the labels “Epratuzumab” and “Anifrolumab” originally both read “IIanalumab”.
-
Sep 30, 2024 |
ard.bmj.com | Andreas Kronbichler |Hans-Joachim Anders |Eleni Frangou |Safak Mirioglu
Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al Free Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Sep 23, 2024 |
nature.com | Hans-Joachim Anders
AbstractLupus nephritis is a common complication of systemic lupus erythematosus (SLE) and a determinant of overall morbidity and mortality, as lupus nephritis-related chronic kidney disease (CKD) drives cardiovascular disease and secondary immunodeficiency.
-
May 15, 2024 |
ard.bmj.com | Maria Soler |Conxita Jacobs Cachá |Hans-Joachim Anders |Policlinic IV
Correspondence on: ‘SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy’ by Zhao et al Free Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Apr 5, 2024 |
ard.bmj.com | Andreas Kronbichler |Hans-Joachim Anders |Eleni Frangou |Safak Mirioglu
Lupus Erythematosus, SystemicLupus NephritisMortalityThe recently published European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) (2023 update)1 recognise the major achievements in treating lupus nephritis (LN).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 3K
- DMs Open
- No
RT @JasmineNephro: 🤩Nephroprotective GLP1 RA-Ways in which they are kidney protective https://t.co/56QYv5Sdxw @NDTsocial @hjanders_hans…
RT @JasmineNephro: 🧐Does high measured GFR leads to ⬆️ risk of all cause/CVS mortality https://t.co/S6W4wreV9H @NDTsocial @hjanders_hans…
RT @NDTsocial: How to individualise renoprotective therapy in obese patients with chronic kidney disease ➡️a commentary by the Diabesity W…